Compare QTRX & SAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QTRX | SAR |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 352.7M | 369.9M |
| IPO Year | 2017 | 2007 |
| Metric | QTRX | SAR |
|---|---|---|
| Price | $6.48 | $23.23 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 4 |
| Target Price | $11.33 | ★ $23.75 |
| AVG Volume (30 Days) | ★ 654.8K | 81.5K |
| Earning Date | 11-10-2025 | 01-07-2026 |
| Dividend Yield | N/A | ★ 12.95% |
| EPS Growth | N/A | ★ 52.15 |
| EPS | N/A | ★ 2.38 |
| Revenue | ★ $130,203,000.00 | $130,118,086.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $28.28 | $1.28 |
| P/E Ratio | ★ N/A | $9.72 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.05 | $21.10 |
| 52 Week High | $12.41 | $26.17 |
| Indicator | QTRX | SAR |
|---|---|---|
| Relative Strength Index (RSI) | 42.84 | 56.70 |
| Support Level | $6.52 | $22.97 |
| Resistance Level | $7.10 | $23.34 |
| Average True Range (ATR) | 0.36 | 0.29 |
| MACD | -0.17 | 0.01 |
| Stochastic Oscillator | 5.64 | 75.51 |
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
Saratoga Investment Corp is a specialty finance company that provides customized financing solutions to U.S. middle-market businesses. The Company invests in senior and unitranche leveraged loans and mezzanine debt, and, to a lesser extent, equity to provide financing for change of ownership transactions, strategic acquisitions, recapitalizations and growth initiatives in partnership with business owners, management teams and financial sponsors. Its objective is to create attractive risk-adjusted returns by generating current income and long-term capital appreciation from its debt and equity investments.